Development of an adenovirus vector vaccine platform for targeting dendritic cells

Adenoviral (Ad) vector vaccines represent one of the most promising modern vaccine platforms, and Ad vector vaccines are currently being investigated in human clinical trials for infectious disease and cancer. Our studies have shown that specific targeting of adenovirus to dendritic cells dramatical...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Piyush K, Dmitriev, Igor P, Kashentseva, Elena A, Raes, Geert, Li, Lijin, Kim, Samuel W, Lu, Zhi-Hong, Arbeit, Jeffrey M, Fleming, Timothy P, Kaliberov, Sergey A, Goedegebuure, S Peter, Curiel, David T, Gillanders, William E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972836/
https://www.ncbi.nlm.nih.gov/pubmed/29242639
http://dx.doi.org/10.1038/s41417-017-0002-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972836/
https://www.ncbi.nlm.nih.gov/pubmed/29242639
http://dx.doi.org/10.1038/s41417-017-0002-1

Ejemplares similares